StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
MDXHBearishLegalnews
Medium materiality6/10

MDXH faces Nasdaq market-value deficiency with 180-day cure window ahead

Jul 24, 2026, 5:01 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Regulatory non-compliance signals potential dilution/financing needs and a delisting risk, which historically weighs on small-cap names and can trigger short-term downside and liquidity concerns.

AI summary

What happened, with direct paths to the underlying reporting

MDxHealth disclosed Nasdaq notified it of a minimum market-value deficiency, with a 180-day window to regain compliance by January 19, 2027. The hurdle requires a market value above $35 million for 10 consecutive trading days. The company says operations are unaffected and will monitor the metric to avoid delisting.

  • Nasdaq notified mdxhealth of market-value deficiency. Must exceed $35M for 10 days to cure.
  • 180-day window to regain compliance; delisting risk if not cured by Jan 19, 2027.
  • Company says operations unaffected; monitoring market value during grace period.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event